日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrated transcriptomic and molecular docking analysis identifies Rhotekin 2 as a promising therapeutic target for overcoming gemcitabine resistance in cholangiocarcinoma

整合转录组学和分子对接分析表明,Rhotekin 2 是克服胆管癌吉西他滨耐药性的一个有前景的治疗靶点。

Kidoikhammouan, Sonexai; Mahalapbutr, Panupong; Ma-In, Prasertsri; Lert-Itthiporn, Worachart; Deenonpoe, Raksawan; Suriya, Utid; Wongkham, Sopit; Seubwai, Wunchana

Soyasaponin-I Attenuates Melanogenesis through Activation of ERK and Suppression of PKA/CREB Signaling Pathways

大豆皂苷-I通过激活ERK和抑制PKA/CREB信号通路来减弱黑色素生成

Ma-In, Prasertsri; Teeravirote, Karuntarat; Mahalapbutr, Panupong; Panawan, Orasa; Luang, Sukanya; Silsirivanit, Atit

Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis

基于乙二醇壳聚糖的载他克莫司纳米胶束疗法可改善狼疮性肾炎

Chang Seong Kim #, Ansuja Pulickal Mathew #, Arathy Vasukutty, Saji Uthaman, Soo Yeon Joo, Eun Hui Bae, Seong Kwon Ma, In-Kyu Park, Soo Wan Kim

An efficient chemical screening method for structure-based inhibitors to nucleic acid enzymes targeting the DNA repair-replication interface and SARS CoV-2

一种针对 DNA 修复-复制界面和 SARS CoV-2 的核酸酶结构抑制剂的有效化学筛选方法

Davide Moiani, Todd M Link, Chris A Brosey, Panagiotis Katsonis, Olivier Lichtarge, Youngchang Kim, Andrzej Joachimiak, Zhijun Ma, In-Kwon Kim, Zamal Ahmed, Darin E Jones, Susan E Tsutakawa, John A Tainer

Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma

碳水化合物抗原50:在肝内胆管癌的诊断和预后预测中的价值

Luang, Sukanya; Teeravirote, Karuntarat; Saentaweesuk, Waraporn; Ma-In, Prasertsri; Silsirivanit, Atit

Tumor necrosis factor α-converting enzyme inhibitor attenuates lipopolysaccharide-induced reactive oxygen species and mitogen-activated protein kinase expression in human renal proximal tubule epithelial cells

肿瘤坏死因子 α 转换酶抑制剂减弱人肾近端小管上皮细胞中脂多糖诱导的活性氧和丝裂原活化蛋白激酶的表达

Eun Hui Bae, In Jin Kim, Hong Sang Choi, Ha Yeon Kim, Chang Seong Kim, Seong Kwon Ma, In S Kim, Soo Wan Kim